medigraphic.com

2020, Número 1

<< Anterior Siguiente >>

Rev Mex Anest 2020; 43 (1)


Enfermedad tromboembólica venosa en el embarazo

Silva-Reyna P

Idioma: Español
Referencias bibliográficas: 49
Paginas: 41-47
Archivo PDF: 259.34 Kb.


RESUMEN

La enfermedad tromboembólica venosa como trombosis venosa profunda y tromboembolismo pulmonar, son causa importante de mortalidad materna, además se han considerado un problema de salud pública en diferentes países. La trombosis venosa profunda y el tromboembolismo pulmonar son considerados parte de una misma enfermedad con diversos síntomas clínicos que afectan al paciente. Algunas cifras epidemiológicas de la enfermedad tromboembólica venosa son que su incidencia se encuentra en torno a 167 por cada 1,000,000 personas por año, en mujeres embarazadas se presenta con una incidencia de 0.5-2.2 por 1,000 embarazos además que es de elevada mortalidad, se ha incrementado en los últimos diez años y en sus factores de riesgo podemos mencionar: trombofilia, tabaquismo, raza, hipertensión, hemorragia obstétrica, transfusiones, obesidad, cesárea principalmente. El abordaje terapéutico dependerá de la expresión clínica de la enfermedad tromboembólica venosa. Por lo que esta revisión incluye datos sobre la epidemiología, patogénesis, inflamación, factores de riesgo relacionados a la enfermedad tromboembólica venosa en el embarazo, la identificación de factores de riesgo no sólo son fundamentales para el diagnóstico, sino que también son importantes para prevenir y tratar la enfermedad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Sociedad Española de Ginecología y Obstetricia (SEGO). Enfermedad tromboembólica venosa en la gestación. Prog Obstet Ginecol. 2013;56:41-64.

  2. Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016;41:3-14.

  3. Simcox LE, Ormesher L, Tower C, Greer IA. Pulmonary thromboembolism in pregnancy: diagnosis and management. Breathe (Sheff). 2015;11:282-289.

  4. Gader AA, Haggaz AE, Adam I. Epidemiology of deep venous thrombosis during pregnancy and puerperium in Sudanese women. Vasc Health Risk Manag. 2009;5:85-87.

  5. Villani M, Ageno W, Grandone E, Dentali F. The prevention and treatment of venous thromboembolism in pregnancy. Expert Rev Cardiovasc Ther. 2017;15:397-402.

  6. Simpson EL, Lawrenson RA, Nightingale AL, Farmer RD. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG. 2001;108:56-60.

  7. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ 3rd. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143:697-706.

  8. Galambosi PJ, Gissler M, Kaaja RJ, Ulander VM. Incidence and risk factors of venous thromboembolism during postpartum period: a population-based cohort-study. Acta Obstet Gynecol Scand. 2017;96:852-861.

  9. Guía de Práctica Clínica Diagnóstico y Tratamiento de la Enfermedad Tromboembólica Venosa, México; Secretaría de Salud, 2010. Disponible en: http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/437_GPC_Enf_troboembolica_venosa/GER_Enfermedad_tromboembxlica_venosa.pdf

  10. Paz-Janeiro JL, Guzmán-Cruz LA, Pérez-Damián V, Barrios-Cedrún IR, Cortina-Nascimento A, Benites-Palacio S y cols. Manejo de la enfermedad tromboembólica venosa. Rev Mex Angiol. 2013;41:69-77.

  11. Alkema L, Chou D, Hogan D, Zhang S, Moller AB, Gemmill A, et al. Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group. Lancet. 2016;387:462-474.

  12. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066-1074.

  13. Chan LY, Tam WH, Lau TK. Venous thromboembolism in pregnant Chinese women. Obstet Gynecol. 2001;98:471-475.

  14. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ 3rd. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143:697-706.

  15. Velasco-Murillo V, Navarrete-Hernández E. Maternal mortality at the Mexican Institute of Social Security, from 1991 to 2005. A period of changes. Rev Med Inst Mex Seguro Soc. 2006;44:S121-128.

  16. Brenner B. Haemostatic changes in pregnancy. Thromb Res. 2004;114:409-414.

  17. Malavasi LO, Arêas MM. Venous thromboembolism prophylaxis in pregnancy. J Vasc Bras. 2016;15:293-301.

  18. Kaski JC, Arrebola-Moreno AL. Inflamación y trombosis en la fibrilación auricular. Rev Esp Cardiol. 2011;64:551-553.

  19. Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, Nacken W, et al. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 2009;5:e1000639.

  20. Fuchs TA, Brill A, Wagner DD. Neutrophil extracellular trap (NET) impact on deep vein thrombosis. Arterioscler Thromb Vasc Biol. 2012;32:1777-1783.

  21. Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA. 2010;107:15880-1585.

  22. James AH, Tapson VF, Goldhaber SZ. Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol. 2005;193:216-219.

  23. James AH. Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol. 2009;29:326-331.

  24. James AH, Tapson VF, Goldhaber SZ. Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol. 2005;193:216-219.

  25. Robertson L, Wu O, Greer I. Thrombophilia and adverse pregnancy outcome. Curr Opin Obstet Gynecol. 2004;16:453-458.

  26. Liu S, Rouleau J, Joseph KS, Sauve R, Liston RM, Young D, et al. Epidemiology of pregnancy-associated venous thromboembolism: a population-based study in Canada. J Obstet Gynaecol Can. 2009;31:611-620.

  27. De Stefano V, Martinelli I, Rossi E, Battaglioli T, Za T, Mannuccio MP, et al. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br J Haematol. 2006;135:386-391.

  28. Dilley A, Austin H, El-Jamil M, Hooper WC, Barnhart E, Evatt BL, et al. Genetic factors associated with thrombosis in pregnancy in a United States population. Am J Obstet Gynecol. 2000;183:1271-1277.

  29. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006;132:171-196.

  30. Liston F, Davies GA. Thromboembolism in the obese pregnant woman. Semin Perinatol. 2011;35:330-334.

  31. Morgan ES, Wilson E, Watkins T, Gao F, Hunt BJ. Maternal obesity and venous thromboembolism. Int J Obstet Anesth. 2012;21:253-263.

  32. Larsen TB, Sørensen HT, Gislum M, Johnsen SP. Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study. Thromb Res. 2007;120:505-509.

  33. James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006;194:1311-1315.

  34. Won HS, Kim DY, Yang MS, Lee SJ, Shin H, Park JB. Pregnancy-induced hypertension, but not gestational diabetes mellitus, is a risk factor for venous thromboembolism in pregnancy. Korean Circ J. 2011;41:23-27.

  35. Virkus RA, Løkkegaard E, Lidegaard Ø, Langhoff-Roos J, Nielsen AK, Rothman KJ, Bergholt T. Risk factors for venous thromboembolism in 1.3 million pregnancies: a nationwide prospective cohort. PLoS One. 2014;9:e96495.

  36. Abbasi N, Balayla J, Laporta DP, Kezouh A, Abenhaim HA. Trends, risk factors and mortality among women with venous thromboembolism during labour and delivery: a population-based study of 8 million births. Arch Gynecol Obstet. 2014;289:275-284.

  37. Goldhaber SZ. Epidemiology of pulmonary embolism. Semin Vasc Med. 2001;1:139-146.

  38. Leung AN, Bull TM, Jaeschke R, Lockwood CJ, Boiselle PM, Hurwitz LM, et al. An official American Thoracic Society/Society of Thoracic Radiology clinical practice guideline: evaluation of suspected pulmonary embolism in pregnancy. Am J Respir Crit Care Med. 2011;184:1200-1208.

  39. Damodaram M, Kaladindi M, Luckit J, Yoong W. D-dimer does notexclude venous thromboembolism (VTE) in pregnancy. J obstet Gynaecol. 2008;28:222-223.

  40. Calvillo Batlles P. Algoritmo para el diagnóstico y el seguimiento de la tromboembolia pulmonar aguda. Radiología. 2017;59:75-87.

  41. Greer IA. Prevention of venous thromboembolism in pregnancy. Eur J Med Res. 2004;9:135-145.

  42. Okoroh EM, Azonobi IC, Grosse SD, Grant AM, Atrash HK, James AH. Prevention of venous thromboembolism in pregnancy: a review of guidelines, 2000-2011. J Womens Health (Larchmt). 2012;21:611-615.

  43. Middeldorp S. How I treat pregnancy-related venous thromboembolism. Blood. 2011;118:5394-5400.

  44. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005;106:401-407.

  45. Tooher R, Gates S, Dowswell T, Davis LJ. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev. 2010;CD001689.

  46. Bain E, Wilson A, Tooher R, Gates S, Davis LJ, Middleton P. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev. 2014;CD001689.

  47. Carrillo ER, Saucedo AH, Núñez BJ, Contreras CN, Escárpita BN, Leal GP y cols. ¿Hospitales enfermos o pacientes enfermos? Parte II Profilaxis de la enfermedad tromboembólica venosa en la Fundación Clínica Médica Sur. Med Sur. 2007;14:176-184.

  48. Chan WS, Rey E, Kent NE; VTE in Pregnancy Guideline Working Group, Chan WS, Kent NE, et al. Venous thromboembolism and antithrombotic therapy in pregnancy. J Obstet Gynaecol Can. 2014;36:527-553.

  49. Bates SM, Middeldorp S, Rodger M, James AH, Greer I. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. J Thromb Thrombolysis. 2016;41:92-128.




2020     |     www.medigraphic.com